Retractable Technologies (RVP) Competitors $0.84 +0.01 (+1.51%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$0.84 0.00 (-0.12%) As of 09/19/2025 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RVP vs. FONR, BDMD, EDAP, NTRB, APYX, VANI, ICCM, QTI, LUNG, and TELAShould you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include Fonar (FONR), Baird Medical Investment (BDMD), EDAP TMS (EDAP), Nutriband (NTRB), Apyx Medical (APYX), Vivani Medical (VANI), IceCure Medical (ICCM), QT Imaging (QTI), Pulmonx (LUNG), and TELA Bio (TELA). These companies are all part of the "medical equipment" industry. Retractable Technologies vs. Its Competitors Fonar Baird Medical Investment EDAP TMS Nutriband Apyx Medical Vivani Medical IceCure Medical QT Imaging Pulmonx TELA Bio Retractable Technologies (NYSE:RVP) and Fonar (NASDAQ:FONR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, media sentiment, analyst recommendations, dividends and profitability. Which has stronger valuation & earnings, RVP or FONR? Fonar has higher revenue and earnings than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRetractable Technologies$38.16M0.66-$7.01M-$0.29-2.90Fonar$102.88M0.91$10.57M$1.2512.11 Do institutionals & insiders hold more shares of RVP or FONR? 7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 50.6% of Fonar shares are owned by institutional investors. 57.1% of Retractable Technologies shares are owned by insiders. Comparatively, 1.6% of Fonar shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is RVP or FONR more profitable? Fonar has a net margin of 8.19% compared to Retractable Technologies' net margin of -41.11%. Fonar's return on equity of 5.31% beat Retractable Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Retractable Technologies-41.11% -17.15% -9.33% Fonar 8.19%5.31%3.97% Which has more risk & volatility, RVP or FONR? Retractable Technologies has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Comparatively, Fonar has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Does the media favor RVP or FONR? In the previous week, Fonar had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for Fonar and 0 mentions for Retractable Technologies. Fonar's average media sentiment score of 0.31 beat Retractable Technologies' score of 0.00 indicating that Fonar is being referred to more favorably in the news media. Company Overall Sentiment Retractable Technologies Neutral Fonar Neutral SummaryFonar beats Retractable Technologies on 11 of the 13 factors compared between the two stocks. Get Retractable Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVP vs. The Competition Export to ExcelMetricRetractable TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$25.18M$75.14M$5.79B$21.60BDividend YieldN/AN/A5.63%3.52%P/E Ratio-1.5611.3980.4329.95Price / Sales0.6640.04534.2260.41Price / Cash48.2518.4137.9924.97Price / Book0.2515.1215.774.59Net Income-$7.01M-$26.48M$3.30B$1.00B7 Day Performance2.31%-4.05%5.37%0.81%1 Month Performance-0.91%4.41%8.10%5.42%1 Year Performance7.95%64.90%81.36%14.47% Retractable Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVPRetractable Technologies0.8079 of 5 stars$0.84+1.5%N/A-6.4%$25.18M$38.16M-1.56240FONRFonar1.1171 of 5 stars$15.70+0.1%N/A-13.0%$95.98M$102.88M12.38480News CoverageUpcoming EarningsAnalyst DowngradeHigh Trading VolumeBDMDBaird Medical InvestmentN/A$2.61+0.4%N/AN/A$93.26MN/A0.00N/AEDAPEDAP TMS2.2592 of 5 stars$2.43+0.6%$8.50+250.5%-17.2%$90.71M$69.18M-3.98230NTRBNutriband2.9725 of 5 stars$6.85+1.6%$13.00+89.9%+28.9%$82.35M$2.14M-2.3910News CoverageAnalyst DowngradeShort Interest ↓APYXApyx Medical2.5736 of 5 stars$2.11-1.2%N/A+110.1%$79.61M$48.10M-4.68270Positive NewsShort Interest ↓VANIVivani Medical3.42 of 5 stars$1.26-0.8%$4.00+217.5%+14.6%$74.64MN/A-2.8020News CoveragePositive NewsInsider TradeICCMIceCure Medical2.4194 of 5 stars$1.04-4.2%$2.39+130.4%+61.6%$71.10M$3.29M-6.4760News CoverageQTIQT ImagingN/A$2.55+6.3%N/A+311.7%$69.19M$4.00M0.00N/AGap DownLUNGPulmonx3.5614 of 5 stars$1.58-0.6%$7.66+385.1%-80.3%$64.42M$90.55M-1.11250Positive NewsTELATELA Bio2.4362 of 5 stars$1.59+0.6%$4.50+183.0%-39.6%$62.99M$75.32M-1.42120 Related Companies and Tools Related Companies FONR Competitors BDMD Competitors EDAP Competitors NTRB Competitors APYX Competitors VANI Competitors ICCM Competitors QTI Competitors LUNG Competitors TELA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RVP) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Retractable Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Retractable Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
